10 Largest AstraZeneca Shareholders In 2023

AstraZeneca is a British-Swedish multinational pharmaceutical company that produces a wide range of products, including prescription drugs, vaccines, and biopharmaceuticals.

The company is one of the largest in the industry, with a market capitalization of around $124 billion as of March 2023.

1. T. Rowe Price Associates, Inc. (I)

T. Rowe Price Associates is a Baltimore-based asset management company that holds 2.21% of AstraZeneca's shares. As of the latest report, the company holds 68,591,648 shares, worth around $4.47 billion.

2. Wellington Management Co. LLP

Wellington Management is a Boston-based investment management firm that holds 1.76% of AstraZeneca's shares. As of the latest report, the company holds 54,606,052 shares, worth around $3.56 billion.

3. PRIMECAP Management Co.

PRIMECAP Management is a Pasadena-based investment management firm that holds 1.45% of AstraZeneca's shares. As of the latest report, the company holds 44,986,840 shares, worth around $2.93 billion.

4. Capital Research & Management Co.

Capital Research & Management is a Los Angeles-based investment management company that holds 1.32% of AstraZeneca's shares. As of the latest report, the company holds 40,798,348 shares, worth around $2.66 billion.

5. GQG Partners LLC

GQG Partners is a Florida-based investment management company that holds 0.56% of AstraZeneca's shares. As of the latest report, the company holds 17,196,471 shares, worth around $1.12 billion.

6. Fidelity Management & Research Co.

Fidelity Management & Research is a Boston-based investment management company that holds 0.53% of AstraZeneca's shares. As of the latest report, the company holds 16,557,326 shares, worth around $1.08 billion.

7. CIBC Private Wealth Advisors, Inc.

CIBC Private Wealth Advisors is a Chicago-based investment management company that holds 0.35% of AstraZeneca's shares. As of the latest report, the company holds 10,767,595 shares, worth around $701 million.

8. Franklin Advisers, Inc.

Franklin Advisers is a San Mateo-based investment management company that holds 0.35% of AstraZeneca's shares. As of the latest report, the company holds 10,737,081 shares, worth around $700 million.

9.Fisher Asset Management LLC

Fisher Asset Management is a Washington-based investment management company that holds 0.28% of AstraZeneca's shares. As of the latest report, the company holds 8,702,421 shares, worth around $567 million.

10. T. Rowe Price International Ltd.

T. Rowe Price International is a London-based investment management company that holds 0.27% of AstraZeneca's shares. As of the latest report, the company holds 8,474,202 shares, worth around $552 million.

Conclusion

It's important to note that the information on AstraZeneca's top shareholders is subject to change over time as investors buy and sell shares.

Nonetheless, these top 10 shareholders hold a significant stake in the company, and their investment decisions can impact AstraZeneca's stock price and overall performance.

This article was generated using automation technology, and thoroughly edited and fact-checked by an editor on our editorial staff.